Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07604870 Metformin Hydrochloride Polyendocrine Metabolic Ovarian Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07604870 clinical trial report covering Metformin Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07518810 Butylphthalide Multiple System Atrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07518810 clinical trial report covering Butylphthalide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07520318 OCUL-101 Geographic Atrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07520318 clinical trial report covering OCUL-101, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07528495 Cisplatin Squamous cell carcinoma of the oral cavity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07528495 clinical trial report covering Cisplatin, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07532603 Brepocitinib Lichen Planus Follicularis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07532603 clinical trial report covering Brepocitinib, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07537075 Ruxuplam Huntington Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07537075 clinical trial report covering Ruxuplam, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07538583 Dipalmitoyl Hydroxyproline Netherton Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07538583 clinical trial report covering Dipalmitoyl Hydroxyproline, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space
Latest Hotspot
8 min read
NCT07535567 Benmelstobart Squamous Cell Carcinoma of Head and Neck Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07535567 clinical trial report covering Benmelstobart, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07537257 Venetoclax Acute Myeloid Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07537257 clinical trial report covering Venetoclax, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07537894 Dexmedetomidine Hydrochloride Abortion Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07537894 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 2/3, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
ChiCTR2600122899 Acetaminophen Pain, Postoperative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
ChiCTR2600122899 clinical trial report covering Acetaminophen, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07539779 Luspatercept-AAMT Hematologic Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07539779 clinical trial report covering Luspatercept-AAMT, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.